BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32274687)

  • 1. Evidence of Clinically Meaningful Drug-Drug Interaction With Concomitant Use of Colchicine and Clarithromycin.
    Villa Zapata L; Hansten PD; Horn JR; Boyce RD; Gephart S; Subbian V; Romero A; Malone DC
    Drug Saf; 2020 Jul; 43(7):661-668. PubMed ID: 32274687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute colchicine intoxication during clarithromycin administration.
    Rollot F; Pajot O; Chauvelot-Moachon L; Nazal EM; Kélaïdi C; Blanche P
    Ann Pharmacother; 2004 Dec; 38(12):2074-7. PubMed ID: 15494379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study.
    Hung IF; Wu AK; Cheng VC; Tang BS; To KW; Yeung CK; Woo PC; Lau SK; Cheung BM; Yuen KY
    Clin Infect Dis; 2005 Aug; 41(3):291-300. PubMed ID: 16007523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute fatal colchicine intoxication in a patient on continuous ambulatory peritoneal dialysis (CAPD). Possible role of clarithromycin administration.
    Dogukan A; Oymak FS; Taskapan H; Güven M; Tokgoz B; Utas C
    Clin Nephrol; 2001 Feb; 55(2):181-2. PubMed ID: 11269688
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs That Interact With Colchicine Via Inhibition of Cytochrome P450 3A4 and P-Glycoprotein: A Signal Detection Analysis Using a Database of Spontaneously Reported Adverse Events (FAERS).
    Gómez-Lumbreras A; Boyce RD; Villa-Zapata L; Tan MS; Hansten PD; Horn J; Malone DC
    Ann Pharmacother; 2023 Oct; 57(10):1137-1146. PubMed ID: 36688283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reductions in Use of Colchicine after FDA Enforcement of Market Exclusivity in a Commercially Insured Population.
    Kesselheim AS; Franklin JM; Kim SC; Seeger JD; Solomon DH
    J Gen Intern Med; 2015 Nov; 30(11):1633-8. PubMed ID: 25855479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine-clarithromycin-induced rhabdomyolysis in Familial Mediterranean Fever patients under treatment for Helicobacter pylori.
    Cohen O; Locketz G; Hershko AY; Gorshtein A; Levy Y
    Rheumatol Int; 2015 Nov; 35(11):1937-41. PubMed ID: 26210999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis.
    McKinnell J; Tayek JA
    J Clin Rheumatol; 2009 Sep; 15(6):303-5. PubMed ID: 19734738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine poisoning: the dark side of an ancient drug.
    Finkelstein Y; Aks SE; Hutson JR; Juurlink DN; Nguyen P; Dubnov-Raz G; Pollak U; Koren G; Bentur Y
    Clin Toxicol (Phila); 2010 Jun; 48(5):407-14. PubMed ID: 20586571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colchicine-antimicrobial drug interactions: what pharmacists need to know in treating gout.
    Davis MW; Wason S; Digiacinto JL
    Consult Pharm; 2013 Mar; 28(3):176-83. PubMed ID: 23462027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colchicine intoxication in familial Mediterranean fever patients using clarithromycin for the treatment of Helicobacter pylori: a series of six patients.
    Haj Yahia S; Ben Zvi I; Livneh A
    Rheumatol Int; 2018 Jan; 38(1):141-147. PubMed ID: 28975396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clarithromycin-associated rhabdomyolysis in an infant.
    Mustafa G; Necati B
    J Clin Rheumatol; 2014 Dec; 20(8):457. PubMed ID: 25417692
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessment of the association between colchicine therapy and serious adverse events.
    Todd BA; Billups SJ; Delate T; Canty KE; Kauffman AB; Rawlings JE; Wagner TM
    Pharmacotherapy; 2012 Nov; 32(11):974-80. PubMed ID: 23019065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colchicine-induced neuromyopathy in a patient with chronic renal failure: the role of clarithromycin.
    van der Velden W; Huussen J; Ter Laak H; de Sévaux R
    Neth J Med; 2008 May; 66(5):204-6. PubMed ID: 18490798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription of Colchicine with Other Dangerous Concomitant Medications: A Nation-Wide Survey Using the Japanese Claims Database.
    Imai S; Momo K; Kashiwagi H; Miyai T; Sugawara M; Takekuma Y
    Biol Pharm Bull; 2020; 43(10):1519-1525. PubMed ID: 32999162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine Drug Interaction Errors and Misunderstandings: Recommendations for Improved Evidence-Based Management.
    Hansten PD; Tan MS; Horn JR; Gomez-Lumbreras A; Villa-Zapata L; Boyce RD; Subbian V; Romero A; Gephart S; Malone DC
    Drug Saf; 2023 Mar; 46(3):223-242. PubMed ID: 36522578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug Interaction Between Febuxostat and Thiopurine Antimetabolites: A Review of the FDA Adverse Event Reporting System and Medical Literature.
    Logan JK; Wickramaratne Senarath Yapa S; Harinstein L; Saluja B; Muñoz M; Sahajwalla C; Neuner R; Seymour S
    Pharmacotherapy; 2020 Feb; 40(2):125-132. PubMed ID: 31885095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute myopathy in a patient with concomitant use of pravastatin and colchicine.
    Alayli G; Cengiz K; Cantürk F; Durmuş D; Akyol Y; Menekşe EB
    Ann Pharmacother; 2005; 39(7-8):1358-61. PubMed ID: 15914514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colchicine's Role in Cardiovascular Disease Management.
    Buckley LF; Libby P
    Arterioscler Thromb Vasc Biol; 2024 May; 44(5):1031-1041. PubMed ID: 38511324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two probable cases of serious drug interaction between clarithromycin and colchicine.
    Cheng VC; Ho PL; Yuen KY
    South Med J; 2005 Aug; 98(8):811-3. PubMed ID: 16144178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.